<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Chemistry</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/30815F9E-A59C-43EC-9A82-1EF149E24DD1"><gtr:id>30815F9E-A59C-43EC-9A82-1EF149E24DD1</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:surname>Paterson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FF025734%2F1"><gtr:id>94777F99-345C-46FF-A850-6B1E277D2AD9</gtr:id><gtr:title>Synthesis of the Brasilinolides</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/F025734/1</gtr:grantReference><gtr:abstractText>The polyketides represent a diverse array of structurally complex natural products having a wide range of biological activity, typically antibiotic, antitumour, antifungal or immunosuppressive action, with many members having important therapeutic utility in human medicine. This project falls within the general theme of complex polyketide synthesis and focuses on the total synthesis of the brasilinolides, which are a novel family of potent immunosuppressive and antifungal 32-membered macrolides with unprecedented structural and stereochemical complexity. The planned synthesis of the brasilinolides draws on and extends contemporary methods of acyclic stereocontrol to efficiently set up the required stereochemistry, with particular emphasis on the use of new methodology recently developed in the Cambridge group. Our approach aims to incorporate maximum flexibility in terms of segment coupling, enabling the synthesis of other stereoisomers if necessary as well as novel analogues, and relies on a versatile combination of reagent and substrate-based control. Altogether, the pronounced biological activities of the brasilinolides, along with their lack of acute toxicity, makes further evaluation as new immunotherapeutic and/or antifungal agents of interest, with potential applications inter alia to autoimmune diseases and in counteracting tissue rejection in organ transplantation. These considerations, along with the significant intellectual challenge and high quality training provided by tackling such complex molecule synthesis, make the brasilinolides an attractive and platform for developing new methodology and strategies, which is also expected to become an exciting arena for further chemical and biological studies. Significantly, this project will build on the considerable expertise that we have developed over the years on the stereocontrolled synthesis of bioactive natural products and their analogues.</gtr:abstractText><gtr:fund><gtr:end>2011-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2007-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>435373</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The research results have facilitated ongoing projects in my group and other groups based on the published outcomes.</gtr:description><gtr:firstYearOfImpact>2010</gtr:firstYearOfImpact><gtr:id>D4C6219D-9574-4D78-ABB1-393C32398DE4</gtr:id><gtr:impactTypes><gtr:impactType>Societal</gtr:impactType></gtr:impactTypes><gtr:outcomeId>544f8d68c287b7.45650339</gtr:outcomeId><gtr:sector>Chemicals,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The polyketides represent a diverse array of structurally complex natural products having a wide range of biological activity, typically antibiotic, antitumour, antifungal or immunosuppressive action, with many members having important therapeutic utility in human medicine. This project falls within the general theme of complex polyketide synthesis and focuses on the total synthesis of the brasilinolides, which are a novel family of potent immunosuppressive and antifungal 32-membered macrolides with unprecedented structural and stereochemical complexity. The planned synthesis of the brasilinolides draws on and extends contemporary methods of acyclic stereocontrol to efficiently set up the required stereochemistry, with particular emphasis on the use of new methodology recently developed in the Cambridge group. Our approach aims to incorporate maximum flexibility in terms of segment coupling, enabling the synthesis of other stereoisomers if necessary as well as novel analogues, and relies on a versatile combination of reagent and substrate-based control. Altogether, the pronounced biological activities of the brasilinolides, along with their lack of acute toxicity, makes further evaluation as new immunotherapeutic and/or antifungal agents of interest, with potential applications inter alia to autoimmune diseases and in counteracting tissue rejection in organ transplantation. These considerations, along with the significant intellectual challenge and high quality training provided by tackling such complex molecule synthesis, make the brasilinolides an attractive and platform for developing new methodology and strategies, which is also expected to become an exciting arena for further chemical and biological studies. Significantly, this project builds on the considerable expertise that we have developed over the years on the stereocontrolled synthesis of bioactive natural products and their analogues. As a sideline to the main project, contributions to the synthesis and structure determination of some other important bioactive polyketides were achieved. To date, this project has resulted in 10 publications in peer-reviewed journals.</gtr:description><gtr:exploitationPathways>the findings are relevant to other work on the stereocontrolled construction of biologically important polyketides</gtr:exploitationPathways><gtr:id>C809C018-FDE3-425D-A8F2-EA0E0E431559</gtr:id><gtr:outcomeId>r-6762001977.080481774fd186</gtr:outcomeId><gtr:sectors><gtr:sector>Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F3469042-2D39-4253-A320-5C9AEE6FF869</gtr:id><gtr:title>Total synthesis of (-)-spirangien A, an antimitotic polyketide isolated from the myxobacterium Sorangium cellulosum.</gtr:title><gtr:parentPublicationTitle>Chemistry, an Asian journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d99abd3beb2e8185bc0935539674c34f"><gtr:id>d99abd3beb2e8185bc0935539674c34f</gtr:id><gtr:otherNames>Paterson I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1861-471X</gtr:issn><gtr:outcomeId>doi_53cfc1fc1def2175</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF5795F2-5188-4EB5-8D98-B9997F3A345A</gtr:id><gtr:title>Total synthesis and configurational validation of (+)-phorbaside A.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d99abd3beb2e8185bc0935539674c34f"><gtr:id>d99abd3beb2e8185bc0935539674c34f</gtr:id><gtr:otherNames>Paterson I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>doi_53d01b01bf067b98</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A5B8F3C-F0E8-430A-8D2A-FEE8F853AAB7</gtr:id><gtr:title>Total synthesis of the marine macrolide (+)-neopeltolide.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d99abd3beb2e8185bc0935539674c34f"><gtr:id>d99abd3beb2e8185bc0935539674c34f</gtr:id><gtr:otherNames>Paterson I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>doi_53d02b02b0512cd4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>857B1AB1-2F50-4C01-82C8-D2306CA9C4B2</gtr:id><gtr:title>An Expedient Total Synthesis of Chivosazole F: an Actin-Binding Antimitotic Macrolide from the Myxobacterium Sorangium Cellulosum.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35619bdd4f121fbd894e14e53a51c608"><gtr:id>35619bdd4f121fbd894e14e53a51c608</gtr:id><gtr:otherNames>Williams S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>5a60f61ac21948.84602682</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51E24CE7-4814-4278-A5D8-0F131B2C2CE0</gtr:id><gtr:title>Leiodermatolide, a potent antimitotic macrolide from the marine sponge Leiodermatium sp.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d99abd3beb2e8185bc0935539674c34f"><gtr:id>d99abd3beb2e8185bc0935539674c34f</gtr:id><gtr:otherNames>Paterson I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>doi_53cfc1fc14950a8e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>777734E3-2A9F-41B9-88A7-C1ECB2DA7942</gtr:id><gtr:title>Total synthesis of (-)-spirangien A and its methyl ester.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d99abd3beb2e8185bc0935539674c34f"><gtr:id>d99abd3beb2e8185bc0935539674c34f</gtr:id><gtr:otherNames>Paterson I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>doi_53d02b02b282689b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>062181BA-F54C-4795-8A35-81E3B331D682</gtr:id><gtr:title>Toward the total synthesis of the brasilinolides: stereocontrolled assembly of a C1-C19 polyol segment.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d99abd3beb2e8185bc0935539674c34f"><gtr:id>d99abd3beb2e8185bc0935539674c34f</gtr:id><gtr:otherNames>Paterson I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>doi_53d01c01c2876e18</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>121D292D-48FF-4CDC-BFB8-71A9B11C8CCB</gtr:id><gtr:title>Synthesis of the C15-C35 northern hemisphere subunit of the chivosazoles.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d99abd3beb2e8185bc0935539674c34f"><gtr:id>d99abd3beb2e8185bc0935539674c34f</gtr:id><gtr:otherNames>Paterson I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>doi_53d01b01bf4656f1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CE88D15-79F2-4E9F-A346-F4FB743E6733</gtr:id><gtr:title>Synthetic Studies towards Iriomoteolide 1a: Stereocontrolled Construction of C1-C9 and C11-C23 Segments Using Lactate Aldol Chemistry</gtr:title><gtr:parentPublicationTitle>Synlett</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d99abd3beb2e8185bc0935539674c34f"><gtr:id>d99abd3beb2e8185bc0935539674c34f</gtr:id><gtr:otherNames>Paterson I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>doi_53d0320323c38cad</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECE55FDC-8638-4F75-8B91-404FD7F2D0C0</gtr:id><gtr:title>Synthetic studies toward the brasilinolides: controlled assembly of a protected C1-C38 polyol based on fragment union by complex aldol reactions.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d99abd3beb2e8185bc0935539674c34f"><gtr:id>d99abd3beb2e8185bc0935539674c34f</gtr:id><gtr:otherNames>Paterson I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>5675e2f58c817</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A955CA23-8D2D-4E77-879E-73D2E9938BAA</gtr:id><gtr:title>Toward the total synthesis of the brasilinolides: construction of a differentially protected C20-C38 segment.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d99abd3beb2e8185bc0935539674c34f"><gtr:id>d99abd3beb2e8185bc0935539674c34f</gtr:id><gtr:otherNames>Paterson I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>doi_53d01c01c29de413</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E165B4B1-13E7-4D78-96F8-D659123DEE76</gtr:id><gtr:title>Synthesis of the C1-C13 tetraenoate subunit of the chivosazoles.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d99abd3beb2e8185bc0935539674c34f"><gtr:id>d99abd3beb2e8185bc0935539674c34f</gtr:id><gtr:otherNames>Paterson I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>doi_53d01b01bf3414b6</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/F025734/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>60EBB420-734E-4DB5-B0F2-65A1115A27F8</gtr:id><gtr:percentage>90</gtr:percentage><gtr:text>Chemical synthesis</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>10</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>0B9701E7-D17F-4963-82DA-B3926A65B50A</gtr:id><gtr:percentage>90</gtr:percentage><gtr:text>Biological &amp; Medicinal Chem.</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>E48C802F-8897-4353-910A-09D09331BB82</gtr:id><gtr:percentage>10</gtr:percentage><gtr:text>Medical science &amp; disease</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>